Chandra Bhagat Pharma Limited (BOM:542934)
India · Delayed Price · Currency is INR 40.50
-0.50 (-1.22%)
At close: Jan 22, 2026
Chandra Bhagat Pharma Revenue
Chandra Bhagat Pharma had revenue of 255.46M INR in the half year ending September 30, 2025, a decrease of -78.58%. This brings the company's revenue in the last twelve months to 493.95M, down -70.63% year-over-year. In the fiscal year ending March 31, 2025, Chandra Bhagat Pharma had annual revenue of 887.67M, down -60.11%.
Revenue (ttm)
493.95M
Revenue Growth
-70.63%
P/S Ratio
0.62
Revenue / Employee
12.35M
Employees
40
Market Cap
305.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 887.67M | -1.34B | -60.11% |
| Mar 31, 2024 | 2.23B | 1.03B | 85.93% |
| Mar 31, 2023 | 1.20B | 255.97M | 27.21% |
| Mar 31, 2022 | 940.76M | 233.79M | 33.07% |
| Mar 31, 2021 | 706.97M | -232.85M | -24.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chemkart India | 1.93B |
| Checkpoint Trends | 1.21B |
| VijayPD Ceutical | 1.07B |
| Dipna Pharmachem | 1.07B |
| Novelix Pharmaceuticals | 849.03M |
| Medico Intercontinental | 822.95M |
| Constronics Infra | 667.12M |
| Medistep Healthcare | 496.55M |